Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Finance 150x110Second Quarter 2017 Financial Results

Genmab will report its Second Quarter 2017 financial results after market close on August 9. An investor conference call to discuss the results will be held at 6PM CEST / 12PM EDT on August 9. To join the call by phone, dial on of the following numbers and ask for the Genmab conference call: +45 32 71 16 60 in Denmark, +44 20 3427 1912 in the UK or +1 646 254 3366 in the US. Click here to listen to the webcast.  

 

Upcoming Events

A list of investor conferences at which Genmab will present, as well as financial report dates and other events, can be found on the Events & Presentations page of this website.  

Download Library

Access Genmab's financial reports, webcasts, presentations and more from the Download Library